Location: Home
  • search
  • go
  • Relate News
  • 10/18/2016CFDA Solicits Public Comments on Three Appendices of GSP
  • 10/18/2016CFDA Solicits Public Comments on Cleanup of Past Official Documents
  • 10/18/2016Zhejiang and Shaanxi Relaxes Non-Essential Drug Inventory Limit in Pri...
  • 10/18/2016Guangdong Introduces New Action Plan for Healthcare Cost Containment
  • 10/17/2016Hua Medicine Announces First-Ever Successful Phase II Monotherapy Tria...
  • 10/17/2016TOT Biopharma Begins Phase II Construction of Its mAb Facility in Suzh...
  • 10/17/2016Fujifilm to Invest HK$806M in China Resources Pharma
  • 10/17/2016GSK Ramps Up Neuroscience R&D in China Thru Local Partnerships
  • 10/14/2016NHFPC, MOF Issue Official Notice to Link Negotiation Outcome and NRCMS...
  • 10/14/2016Data Snapshot: Urban Public Hospital Market for Chemical Drugs
  • 10/14/2016National Cancer Center Releases Official Chinese Cancer Prevalence Dat...
  • 10/14/2016Five Central Government Agencies Issues Two Health Science & Techn...
  • 10/14/2016Novartis Cuts More R&D Jobs, Closing Chinese and Swiss Locatio...
  • 10/13/2016Kymab, EpimAb Enter Multi-Target, Bispecific Antibody Cross-Licensing ...
  • 10/13/2016Green Cross Refocuses on China As It Halts US Trials of Hemophilia Dru...
  • 10/13/2016TransThera Biosciences Raises $10M in Round A to Develop Novel NCE Dru...
  • 10/13/2016FDA Bans Import from Another Chinese Drug Manufacturer
  • 10/13/2016Certara Establishes Phoenix PK/PD Centers of Excellence in China and J...
  • 10/13/2016Recent Executive Moves
  • 10/12/2016Flourishing Telecare in China Means Opportunities for MNC Pharma Cos: ...
  • 10/12/2016WuXi AppTec Opens Biopharma Manufacturing Facility in Philadephia
  • 10/12/2016Drug Registration Approval and Application Update Q3/2016
  • 10/11/2016Baidu Launches Medical Chatbot to Help Doctors Collect Patient Info
  • 10/11/2016Note To The Chinese FDA: When 80% Of Your Data Is Bad, How Trustworthy...
  • 10/11/2016CFDA Issues Draft Guidelines for Drug Data Management for Public Comme...
  • 10/10/2016AstraZeneca, 3SBio Enter Exclusive Licensing Agreement for Byetta and ...
  • 10/10/2016China Resources Pharma Raises $1.8 Bln in Hong Kong IPO
  • 10/10/2016Fosun Pharma Joins Hands with Intuitive Surgical on Lung Cancer
  • 10/10/2016Anhui Officially Introduces "Two Invoice" System
  • 10/10/2016MOHRSS: 2/3 of Provincial Level Governments Introduced Plan to Integra...
  • Page:386/775 Total number of articles:23233: [First][<<] [384] [385] [386] [387] [388] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group